Antidepressant Effect of Theta-Burst rTMS
只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态
赞助商
Rambam Health Care Campus
临床试验: NCT00515658
BioSeek: nct00515658
关键词
抽象
The aim of this study is to evaluate the safety and efficacy of theta-burst rTMS in patients with major depression. Patients will be randomized to receive ether left-sided intermittent theta-burst rTMS or rigt-sided continuous theta-burst rTMS or sham theta-burst rTMS over two weeks period with an option for an additional two weeks period, depending on treatment response. Clinical assessments will be performed weekly by the Hamilton depression rating scale. In addition, standard neurophysiological assessment of cortical excitability will be done.
日期
| 最后验证: | 07/31/2007 |
| 首次提交: | 08/12/2007 |
| 提交的预估入学人数: | 08/12/2007 |
| 首次发布: | 08/13/2007 |
| 上次提交的更新: | 08/12/2007 |
| 最近更新发布: | 08/13/2007 |
| 实际学习开始日期: | 02/28/2007 |
状况或疾病
Major Depression
干预/治疗
Device: theta-burst rTMS
相
相 2
资格标准
| 有资格学习的年龄 | 18 Years 至 18 Years |
| 有资格学习的性别 | All |
| 接受健康志愿者 | 是 |
| 标准 | Inclusion Criteria: - Major depressive episode (DSM IV criteria). - Informed consent. - Age: 18-70. Exclusion Criteria: - Suicidality - Psychosis - Pacemaker - Cardiac arrythmia - seizure disorder - implantable metal devices - PNS and CNS disorders - any other contraindications as specified in safety guidelines for rTMS (Wassermenn, 1998). |
